source
- Open-access fees rise to $12,850 for NIH-funded study in Nature MedicineIn 2025 a randomized clinical trial led by Elizabeth Selvin was published in Nature Medicine without any publication charge. The paper underwent peer review and editorial processing at no cost to t…
- Parabilis Medicines raises $670 million in record-setting biotech IPO on NasdaqParabilis Medicines, a Cambridge, Massachusetts drug developer, completed its initial public offering on Nasdaq, raising $670 million. The offering is described as the largest biotech IPO in indus…